Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Olaparib combined with abiraterone in patients with metas... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a randomised, double-blind, placebo-controlled, phase 2 trial
0
Authors
Noel Clarke
15 more
Noel Clarke
•
Paweł Wiechno
13 more
•
Fred Saad
Published
June 4, 2018
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet Oncology
Topics
Chemistry
Biochemistry
Medicine
Cancer Oncology
Pathology
Show all topics
DOI
10.1016/s1470-2045(18)30365-6
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet Oncology
Topics
Chemistry
Biochemistry
Medicine
Cancer Oncology
Pathology
Show all topics
DOI
10.1016/s1470-2045(18)30365-6
Other Formats
PDF
